SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 46186.00 millions, down -31.03% for the September 2025 quarter as against Rs. 66963.00 millions during the year-ago period.The company reported a drastic decline of -79.42% in the quarter ended September 2025 to Rs. 3873.00  millions from Rs. 18821.00 millions  .Operating Profit reported a sharp decline to 8445.00 millions from 29292.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 46186.00 66963.00 -31.03 124281.00 125375.00 -0.87 231154.00 194838.00 18.64
Other Income 3642.00 2076.00 75.43 7625.00 4254.00 79.24 10034.00 8623.00 16.36
PBIDT 8445.00 29292.00 -71.17 50798.00 51000.00 -0.40 83852.00 67887.00 23.52
Interest 334.00 284.00 17.61 526.00 355.00 48.17 1099.00 218.00 404.13
PBDT 8111.00 29008.00 -72.04 50272.00 50645.00 -0.74 82753.00 67669.00 22.29
Depreciation 2948.00 2600.00 13.38 5746.00 5098.00 12.71 10394.00 9756.00 6.54
PBT 5163.00 26408.00 -80.45 44526.00 45547.00 -2.24 72359.00 57913.00 24.94
TAX 1290.00 7587.00 -83.00 11041.00 12554.00 -12.05 18865.00 14493.00 30.17
Deferred Tax 513.00 554.00 -7.40 847.00 855.00 -0.94 960.00 875.00 9.71
PAT 3873.00 18821.00 -79.42 33485.00 32993.00 1.49 53494.00 43420.00 23.20
Equity 835.00 834.00 0.12 835.00 834.00 0.12 834.00 834.00 0.00
PBIDTM(%) 18.28 43.74 -58.20 40.87 40.68 0.48 36.28 34.84 4.11

Dr. Reddys Lab Share Price

1220.75 -11.50 (-0.93%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×